Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

268 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Genetic deletion of trace amine 1 receptors reveals their role in auto-inhibiting the actions of ecstasy (MDMA).
Di Cara B, Maggio R, Aloisi G, Rivet JM, Lundius EG, Yoshitake T, Svenningsson P, Brocco M, Gobert A, De Groote L, Cistarelli L, Veiga S, De Montrion C, Rodriguez M, Galizzi JP, Lockhart BP, Cogé F, Boutin JA, Vayer P, Verdouw PM, Groenink L, Millan MJ. Di Cara B, et al. Among authors: maggio r. J Neurosci. 2011 Nov 23;31(47):16928-40. doi: 10.1523/JNEUROSCI.2502-11.2011. J Neurosci. 2011. PMID: 22114263 Free PMC article.
Partial agonist actions of aripiprazole and the candidate antipsychotics S33592, bifeprunox, N-desmethylclozapine and preclamol at dopamine D(2L) receptors are modified by co-transfection of D(3) receptors: potential role of heterodimer formation.
Novi F, Millan MJ, Corsini GU, Maggio R. Novi F, et al. Among authors: maggio r. J Neurochem. 2007 Aug;102(4):1410-24. doi: 10.1111/j.1471-4159.2007.04660.x. Epub 2007 May 26. J Neurochem. 2007. PMID: 17532788 Free article.
S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent: I. Receptor-binding profile and functional actions at G-protein-coupled receptors.
Millan MJ, Mannoury la Cour C, Novi F, Maggio R, Audinot V, Newman-Tancredi A, Cussac D, Pasteau V, Boutin JA, Dubuffet T, Lavielle G. Millan MJ, et al. Among authors: maggio r. J Pharmacol Exp Ther. 2008 Feb;324(2):587-99. doi: 10.1124/jpet.107.126706. Epub 2007 Nov 16. J Pharmacol Exp Ther. 2008. PMID: 18024789
Differential induction of adenylyl cyclase supersensitivity by antiparkinson drugs acting as agonists at dopamine D1/D2/D3 receptors vs D2/D3 receptors only: parallel observations from co-transfected human and native cerebral receptors.
Aloisi G, Silvano E, Rossi M, Millan MJ, Maggio R. Aloisi G, et al. Among authors: maggio r. Neuropharmacology. 2011 Feb-Mar;60(2-3):439-45. doi: 10.1016/j.neuropharm.2010.10.018. Epub 2010 Oct 28. Neuropharmacology. 2011. PMID: 21035472
268 results